Owens & Minor (OMI) Stock Price, News & Analysis

Company Overview

Owens & Minor, Inc. is a global healthcare solutions company specializing in the distribution of medical and surgical supplies, as well as supply chain management services. The company partners with healthcare providers, manufacturers and group purchasing organizations to deliver critical products and customized logistics solutions across the continuum of care. Its offerings range from standard medical-surgical products to specialized clinical devices, all supported by technology-driven inventory management and consulting services aimed at optimizing operational efficiency for hospitals, ambulatory surgery centers and other care facilities.

Founded in 1882 and headquartered in Mechanicsville, Virginia, Owens & Minor has evolved from a regional pharmaceutical distributor into a leader in healthcare logistics. Over its history, the company has expanded through strategic acquisitions and investments in supply chain technology. This evolution has allowed it to address the complex needs of a modern healthcare system, including the integration of data analytics, automated warehousing and customized transportation solutions.

Owens & Minor operates across two core segments: U.S. and International. In the United States, it maintains a network of distribution centers and service hubs that support acute care, alternate site and government healthcare channels. Its international segment serves customers in Europe and select Asia-Pacific markets, providing last-mile delivery, clinical consulting and market-specific product sourcing. The company’s global reach enables it to navigate diverse regulatory environments and supply chain challenges.

Led by President and Chief Executive Officer Edward Pesicka, Owens & Minor emphasizes continuous innovation in healthcare logistics. The leadership team combines expertise in supply chain engineering, clinical operations and digital transformation to address evolving industry demands. By aligning strategic partnerships, technology and service capabilities, the company aims to enhance patient outcomes and cost-effectively support healthcare providers worldwide.

Key Stats

• Today's Range: $2.69 to $2.82
• 50-Day Range: $2.49 to $3.17
• 52-Week Range: $2.38 to $9.55
• Volume: 1.27 million shs
• Average Volume: 1.79 million shs
• Market Capitalization: $223.92 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $6.35
• Consensus Rating: Reduce

Owens & Minor Stock Analysis - MarketRank™

Owens & Minor scored higher than 44% of companies evaluated by MarketBeat, and ranked 569th out of 856 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.9 / 5
• Analyst Rating: Reduce

Consensus Rating

Owens & Minor has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no strong buy ratings, 3 buy ratings, no hold ratings, and 4 sell ratings.

Upside Potential

Owens & Minor has a consensus price target of $6.35, representing about 119.3% upside from its current price of $2.90.

Amount of Analyst Coverage

Owens & Minor has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 16.56%

Earnings Growth

Earnings for Owens & Minor are expected to grow by 16.56% in the coming year, from $1.51 to $1.76 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Owens & Minor is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Owens & Minor is -0.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Owens & Minor has a P/B Ratio of 0.39. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for OMI.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Owens & Minor does not currently pay a dividend.

Dividend Growth

Owens & Minor does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

3 people have searched for OMI on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Owens & Minor insiders have not sold or bought any company stock.

Percentage Held by Insiders

3.69% of the stock of Owens & Minor is held by insiders.

Percentage Held by Institutions

98.04% of the stock of Owens & Minor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OMI Stock Analysis - Frequently Asked Questions

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) issued its quarterly earnings results on Thursday, October, 30th. The company reported $0.25 earnings per share for the quarter, beating analysts' consensus estimates of $0.23 by $0.02. Owens & Minor's revenue for the quarter was up 1.5% compared to the same quarter last year.
Read the conference call transcript.

Is Owens & Minor doing a stock buyback?

Owens & Minor's board approved a share repurchase plan on Friday, February 28th 2025, which allows the company to repurchase $100,000,000 in shares, according to EventVestor. This means that the company could buy up to 13.6% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's leadership believes its stock is undervalued.

Does Owens & Minor have any subsidiaries?

The following companies are subsidiaries of Owens & Minor: Halyard Health - S&IP, Byram Healthcare Centers, ArcRoyal, Medical Action Industries, Movianto, The Burrows Company, McKesson's Acute-Care Medical, and others.

Who are Owens & Minor's major shareholders?

Top institutional shareholders of Owens & Minor include SG Americas Securities LLC (0.08%). Insiders that own company stock include Coliseum Capital Management, L, Edward A Pesicka, Perry A Bernocchi, Jonathan A Leon, Michael Wayne Lowry, Snehashish Sarkar, Heath H Galloway, Alexander J Bruni and Mark A Beck.
View institutional ownership trends.

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Owens & Minor investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 10/30/2025
• Today: 5/05/2026
• AGM 2026: 5/14/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:OMI
• CIK: 75252
• Web: www.owens-minor.com
• Phone: (804) 723-7000
• Fax: 804-723-7100
• Employees: 23,200
• Year Founded: 1882

Price Target and Rating

• Average Price Target for Owens & Minor: $6.35
• High Price Target: $7.00
• Low Price Target: $4.75
• Potential Upside/Downside: +119.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.86
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): ($17.40)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 1.92
• P/E Growth: N/A
• Net Income: -$362.69 million
• Net Margins: -19.99%
• Pretax Margin: -6.64%
• Return on Equity: 95.57%
• Return on Assets: 2.30%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.86
• Quick Ratio: 0.84

Sales & Book Value

• Annual Sales: $10.77 billion
• Price / Sales: 0.02
• Cash Flow: $9.34 per share
• Price / Cash Flow: 0.31
• Book Value: $7.33 per share
• Price / Book: 0.39

Miscellaneous

• Outstanding Shares: 77,347,000
• Free Float: 74,493,000
• Market Cap: $223.92 million
• Optionable: Optionable
• Beta: 1.37